<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16110">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02897154</url>
  </required_header>
  <id_info>
    <org_study_id>CS-2016-0003</org_study_id>
    <nct_id>NCT02897154</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of i-STAT Analyzer</brief_title>
  <official_title>Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Point of Care</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Point of Care</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to compare the performance of two i-STAT Analyzers in a
      Point-of-Care (POC) setting. The evaluation will be performed using a cartridge to test
      glucose, hematocrit and sodium on capillary specimens.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">May 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose (mg/dL) levels</measure>
    <time_frame>Patient's blood is tested within 3 minutes of blood collection</time_frame>
    <description>Data analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hematocrit (%PCV) levels</measure>
    <time_frame>Patient's blood is tested within 3 minutes of blood collection</time_frame>
    <description>Data analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sodium (mmol/L) levels</measure>
    <time_frame>Patient's blood is tested within 3 minutes of blood collection</time_frame>
    <description>Data analysis</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Neonatal Hypoglycemia</condition>
  <condition>Pancreatic Islet Cell Carcinoma</condition>
  <condition>Anemia</condition>
  <condition>Erythrocytosis</condition>
  <condition>Electrolyte Imbalances</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adults (18 years or older)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is â‰¥ 18 years of age

          -  Subjects (or their legal representative) who are willing to voluntarily consent to
             the study

        Exclusion Criteria:

          -  There are no exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris P Edwards, BSc</last_name>
    <role>Study Director</role>
    <affiliation>Abbott Point of Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerard Herro, MS, PMP</last_name>
    <phone>763-588-9813</phone>
    <email>gherro@namsa.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Diablo Clinical Research</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vai Lee</last_name>
      <phone>925-930-7267</phone>
    </contact>
    <investigator>
      <last_name>Mark Christiansen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kentucky Clinical Trials Laboratory</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunet Calderon</last_name>
      <phone>502-569-0337</phone>
      <email>ycalderon@kentuckyctl.com</email>
    </contact>
    <investigator>
      <last_name>Saeed A Jortani, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Stoianoff, BSHA, MBA</last_name>
      <phone>216-444-0231</phone>
    </contact>
    <investigator>
      <last_name>Eric Anderson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>March 27, 2017</lastchanged_date>
  <firstreceived_date>July 6, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
    <mesh_term>Carcinoma, Islet Cell</mesh_term>
    <mesh_term>Polycythemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
